Does PEMBROLIZUMAB Cause Cardiogenic shock? 130 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 130 reports of Cardiogenic shock have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 0.2% of all adverse event reports for PEMBROLIZUMAB.
130
Reports of Cardiogenic shock with PEMBROLIZUMAB
0.2%
of all PEMBROLIZUMAB reports
47
Deaths
74
Hospitalizations
How Dangerous Is Cardiogenic shock From PEMBROLIZUMAB?
Of the 130 reports, 47 (36.2%) resulted in death, 74 (56.9%) required hospitalization, and 54 (41.5%) were considered life-threatening.
Is Cardiogenic shock Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PEMBROLIZUMAB. However, 130 reports have been filed with the FAERS database.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause Cardiogenic shock?
AMLODIPINE (779)
AMIODARONE (595)
BUPROPION (559)
ACETAMINOPHEN (466)
METOPROLOL (454)
BISOPROLOL (413)
VERAPAMIL (412)
NOREPINEPHRINE (381)
HEPARIN (357)
METFORMIN (356)
Which PEMBROLIZUMAB Alternatives Have Lower Cardiogenic shock Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G